<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2021.789521</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of Baduanjin Exercise on Physical Function and Health-Related Quality of Life in Peritoneal Dialysis Patients: A Randomized Trial</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Fan</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1560340/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Liao</surname> <given-names>Jing</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Weihong</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Hui</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1560354/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Liuyan</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Shen</surname> <given-names>Qiyun</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Huachun</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1501201/overview"/>
</contrib>
</contrib-group>
<aff><institution>Longhua Hospital, Shanghai University of Traditional Chinese Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: John William Larkin, Fresenius Medical Care, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Paul Bennett, University of South Australia, Australia; Myriam Isnard, Nephrologist Medipole, France</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Huachun Zhang <email>lhhlky&#x00040;163.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Nephrology, a section of the journal Frontiers in Medicine</p></fn>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors share first authorship</p></fn></author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>789521</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Zhang, Liao, Zhang, Wang, Huang, Shen and Zhang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Zhang, Liao, Zhang, Wang, Huang, Shen and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p><bold>Background and Aims:</bold> Exercise is an efficient non-pharmacological intervention for chronic kidney disease. The study aims to evaluate the effects of Baduanjin exercise on physical function and health-related quality of life (HRQOL) in peritoneal dialysis (PD) patients.</p>
<p><bold>Methods:</bold> Seventy PD patients were randomly assigned to either the Baduanjin exercise group or the control group. Fifty-seven patients completed the study (exercise group, 25; control group, 32). The exercise group received the Baduanjin exercise program for 12 weeks. The control group received usual care. Three well-established performance-based tests determined physical function: five times sit-to-stand test (FTSST), timed up and go test (TUGT), and handgrip strength (HGS). HRQOL was assessed by the Kidney Disease Quality of Life-Short Form.</p>
<p><bold>Results:</bold> At baseline, no differences in physical function and HRQOL were observed between the Baduanjin exercise and the control group. At follow-up, the Baduanjin exercise group showed a marginally significant improvement in FTSST (<italic>P</italic> = 0.008) and TUGT (<italic>P</italic> = 0.040) over the 12 weeks compared to the control group. HRQOL in the Baduanjin exercise group was significantly higher than that of the control group.</p>
<p><bold>Conclusions:</bold> A 12-week Baduanjin exercise program may improve physical function and HRQOL in PD patients. Longer follow-up is needed to determine if these findings will translate into clinical application.</p></abstract>
<kwd-group>
<kwd>Baduanjin</kwd>
<kwd>exercise</kwd>
<kwd>peritoneal dialysis</kwd>
<kwd>physical function</kwd>
<kwd>quality of life</kwd>
</kwd-group>
<contract-sponsor id="cn001">Longhua Hospital Shanghai University of Traditional Chinese Medicine<named-content content-type="fundref-id">10.13039/501100013070</named-content></contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="27"/>
<page-count count="7"/>
<word-count count="3808"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Chronic kidney disease (CKD) is a growing public health concern in China due to its high prevalence with an incidence of &#x0007E;10.8% in adults (<xref ref-type="bibr" rid="B1">1</xref>), association with increased morbidity, mortality, and progression to end-stage renal disease (ESRD) (<xref ref-type="bibr" rid="B2">2</xref>). Peritoneal dialysis (PD) is one of the renal replacement therapies for patients with ESRD. The estimated prevalence of PD was 39.95 per million population in China, and the corresponding number of PD patients was &#x0007E;55,000 (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>PD patients generally engage in a low level of physical activity compared to healthy individuals, reducing exercise capacity, decreasing anabolic stimuli, and compromising muscle endurance, muscle strength, and cardiopulmonary fitness (<xref ref-type="bibr" rid="B4">4</xref>). Meanwhile, physical inactivity is an independent risk factor for lower health-related quality of life (HRQOL) and higher mortality in PD patients (<xref ref-type="bibr" rid="B5">5</xref>). Therefore, most researchers reported exercise as one of the best non-pharmacologic therapies to treat CKD (<xref ref-type="bibr" rid="B6">6</xref>), as it may have a protective role concerning residual renal function (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>PD treatment may imply some challenging and specific physical factors. Whether to exercise with fluid in the abdomen or without is still a controversial issue (<xref ref-type="bibr" rid="B6">6</xref>). In general, PD patients should perform moderate-to-high intensity exercise when there is no dialysis fluid in the abdominal cavity, while low-intensity exercise (e.g., walking) can be performed while dialysis fluid left (<xref ref-type="bibr" rid="B8">8</xref>). In addition, added weight, hernias, dialysate leakage, and uncertainty exercise prescription limited participation in exercise programs in PD patients due to little known about it (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>As one of the traditional Chinese exercises, Baduanjin is an aerobic mind-body exercise with low-to-moderate intensity physical activity that is safe for non-communicable diseases and older individuals (<xref ref-type="bibr" rid="B10">10</xref>). At present, it has been confirmed that the incorporation of Baduanjin exercise into the lifestyle can significantly improve pulmonary function in patients with the chronic obstructive pulmonary disease (<xref ref-type="bibr" rid="B11">11</xref>), glycemic control in patients with diabetes (<xref ref-type="bibr" rid="B12">12</xref>), fatigue in patients with heart failure (<xref ref-type="bibr" rid="B13">13</xref>), and insomnia symptoms (<xref ref-type="bibr" rid="B14">14</xref>). However, what is not yet clear is the impact of Baduanjin on PD patients.</p>
<p>To fill the knowledge gap, the purpose of this study is to evaluate the effectiveness of a Baduanjin exercise program on physical function and HRQOL in PD patients.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Study Population</title>
<p>Participants were identified from the Department of Nephrology, Longhua Hospital Shanghai University Traditional Chinese Medicine. They were included if they were 18 years or older, were diagnosed as CKD according to the Nation Kidney Foundation-Kidney Disease Outcomes Quality Initiative guidelines (<xref ref-type="bibr" rid="B15">15</xref>), and received PD therapy for more than 3 months, and patients were followed regularly at the outpatient clinic every 2 weeks unless loss to follow-up.</p>
<p>Patients were excluded if they needed crutches to walk, had unstable medical conditions (e.g., uncontrolled hypertension: blood pressure &#x0003E;160/100 mmHg, cardiovascular disease (e.g., congestive heart failure)), had participated in similar exercise intervention within the prior 6 months.</p>
</sec>
<sec>
<title>Dialysis Protocol</title>
<p>All patients were treated with glucose-based dialysis fluid for continuous ambulatory peritoneal dialysis containing a 1.5 mmol/L or 2.5 mmol/L concentration. The dialysis frequency was 3&#x02013;4 times/d, and each abdominal retention time was 3&#x02013;5 h. Daily dialysate volume was 6&#x02013;8 L per day.</p>
</sec>
<sec>
<title>Study Procedure</title>
<p>The study was proved by the Ethics Committee of Longhua Hospital Shanghai University Traditional Chinese Medicine. All patients included in this study signed informed consent. Patients were randomly assigned to two groups of Baduanjin exercise group and control group by a researcher using a computer-generated table of random numbers (random seed: 20190101). The study recruitment process is outlined in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Flow of patients through the study. Of 100 patients who were screened, 70 patients were considered eligible and were randomly assigned to the Baduanjin exercise group or control group. In the exercise group, 25 patients completed the study, compared with 32 patients in the control group.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-08-789521-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Control Group</title>
<p>As usual care, nurses provided PD patients with usual care (e.g., conventional medication, routine health guidance) and management strategies for PD-related complications at each outpatient visit.</p>
</sec>
<sec>
<title>Baduanjin Exercise Group</title>
<p>Participants allocated to the exercise group received a 12-week home-based Baduanjin exercise program. Before the Baduanjin exercise program, three nurses (LJ, ZHW, and WH) received professional training to provide Baduanjin instruction to the participants. The Baduanjin exercise program includes eight forms (<xref ref-type="fig" rid="F2">Figure 2</xref>): form 1, propping un the sky; form 2, drawing the bow; form 3, raising one hand; form 4, looking over the shoulders; form 5, clenching fists and looking forward with eyes wide open; form 6, pulling the toes; form 7, swaying head and buttocks; form 8, jolting, and about 30 min each time. The duration of intervention was five times a week for 12 weeks, and supervision was provided via <italic>WeChat</italic> message by the trained researchers (LJ, ZHW, and WH). Because Baduanjin is a low-intensity aerobic exercise, patients can perform it while the dialysis fluid is retained in the abdomen (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Graphic of Baduanjin. (Extracted from &#x0201C;Wu Shu Shi Jie Pin Dao&#x0201D;, a WeChat Official Account).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-08-789521-g0002.tif"/>
</fig>
</sec>
<sec>
<title>Primary Outcome</title>
<p>Three well-established performance-based tests were used to assess changes in physical function (<xref ref-type="bibr" rid="B16">16</xref>). The five times sit-to-stand test (FTSST) measured lower-extremity muscle strength as a function of the time patients needed to stand up from a seated position and sit back down five times from a chair of standardized height. The timed up and go test (TUGT) was used to measure functional mobility that the time needed to stand up from a chair, walk 3 m, and return to the chair and sit down. The handgrip strength (HGS) was used to measure forelimb muscle strength with a dynamograph.</p>
</sec>
<sec>
<title>Secondary Outcome</title>
<p>The Kidney Disease Quality of Life-Short Form (KDQOL-SF) scale version 1.3 assessed HRQOL in PD patients (<xref ref-type="bibr" rid="B17">17</xref>). The scale included 36 items in five dimensions: physical component score, mental component score, burden of kidney disease, symptom/problem, and effect of kidney disease. According to published guidelines, we calculated and linearly converted KDQOL scores to a 0- to 100-point scale, with higher scores reflecting better HRQOL (<xref ref-type="bibr" rid="B18">18</xref>). The Cronbach&#x00027;s alpha and test-retest reliability for the Chinese version of the KDQOL-SF was 0.69&#x02013;0.78 and 0.70&#x02013;0.86, respectively (<xref ref-type="bibr" rid="B19">19</xref>).</p>
</sec>
<sec>
<title>Data Analysis</title>
<p>Data were analyzed using SPSS statistics version 21.0 (IBM Corporation, Armonk, NY, USA). Continuous data were assessed for normality using the Shapiro-Wilk normality test. Data conformance to the normal distribution is described by mean &#x000B1; standard deviation (x &#x000B1; SD), and the <italic>t</italic>-test was used to compare the data. Otherwise, non-normal distribution data were expressed as median (quartile range) and were compared using the Mann-Whitney <italic>U</italic> test. The counting data were expressed as percentages (%), processed by chi-square (&#x003C7;<sup>2</sup>) test. <italic>P</italic> &#x0003C; 0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Participants</title>
<p>Fifty-seven Patients completed the study. Ten participants from the exercise group (two occurred peritonitis and eight because of poor adherence) and three patients from the control group (due to catheter infection) dropped out before the 12-week visit (<xref ref-type="fig" rid="F1">Figure 1</xref>). Participants&#x00027; demographic and clinical characteristics are described in <xref ref-type="table" rid="T1">Table 1</xref>. Sex, age, duration of PD, education, body mass index (BMI), cause of ESRD, and medications were not significantly different between the control and Baduanjin exercise groups (<italic>P</italic> &#x0003E; 0.05).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Baseline characteristics between Baduanjin exercise and control groups.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th valign="top" align="center"><bold>Baduanjin</bold><break/><bold>exercise group</bold><break/><bold>(<italic>n</italic> &#x0003D; 25)</bold></th>
<th valign="top" align="center"><bold>Control group</bold><break/><bold>(<italic>n</italic> &#x0003D; 32)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age, years, median (IQR)</td>
<td valign="top" align="center">60.0 (51.0, 66.0)</td>
<td valign="top" align="center">62.0 (54.5, 67.3)</td>
<td valign="top" align="center">0.535</td>
</tr>
<tr>
<td valign="top" align="left">Duration of PD, months, median (IQR)</td>
<td valign="top" align="center">60.0<break/>(27.0, 118.0)</td>
<td valign="top" align="center">35.5<break/>(23.5, 102.0)</td>
<td valign="top" align="center">0.260</td>
</tr>
<tr>
<td valign="top" align="left">BMI (kg/m<sup>2</sup>), mean &#x000B1; SD</td>
<td valign="top" align="center">22.4 &#x000B1; 3.3</td>
<td valign="top" align="center">22.9 &#x000B1; 3.1</td>
<td valign="top" align="center">0.560</td>
</tr>
<tr>
<td valign="top" align="left">Sex, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.985</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Male</td>
<td valign="top" align="center">14 (56.0%)</td>
<td valign="top" align="center">18 (56.3%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Female</td>
<td valign="top" align="center">11 (44.0%)</td>
<td valign="top" align="center">14 (43.8%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Education, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.578</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;High school and above</td>
<td valign="top" align="center">12 (48.0%)</td>
<td valign="top" align="center">13 (40.6%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Middle school and below</td>
<td valign="top" align="center">13 (52.0%)</td>
<td valign="top" align="center">19 (59.4%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Cause of ESRD, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.229</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Glomerulonephritis</td>
<td valign="top" align="center">15 (60.0%)</td>
<td valign="top" align="center">11 (34.4%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Hypertension</td>
<td valign="top" align="center">2 (8.0%)</td>
<td valign="top" align="center">9 (28.1%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Diatebes</td>
<td valign="top" align="center">2 (8.0%)</td>
<td valign="top" align="center">2 (6.3%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Ig A nephropathy</td>
<td valign="top" align="center">1 (4.0%)</td>
<td valign="top" align="center">3 (9.4%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Other</td>
<td valign="top" align="center">5 (20.0%)</td>
<td valign="top" align="center">7 (21.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Medications, <italic>n</italic> (%)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Antihypertensives</td>
<td valign="top" align="center">12 (48.0%)</td>
<td valign="top" align="center">20 (62.5%)</td>
<td valign="top" align="center">0.274</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Antidiabetics</td>
<td valign="top" align="center">6 (24.0%)</td>
<td valign="top" align="center">8 (25.0%)</td>
<td valign="top" align="center">0.931</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Erythropoietic stimulant</td>
<td valign="top" align="center">16 (64.0%)</td>
<td valign="top" align="center">14 (43.8%)</td>
<td valign="top" align="center">0.129</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Antidyslipidemic</td>
<td valign="top" align="center">9 (36.0%)</td>
<td valign="top" align="center">9 (28.1%)</td>
<td valign="top" align="center">0.526</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>BMI, body mass index; ESRD, end stage renal disease; PD, peritoneal dialysis; IQR, interquartile range; SD, standard deviation</italic>.</p>
<p><italic><sup>&#x02020;</sup>Denotes a 2-sided Fisher exact test</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Physical Function</title>
<p>There was no significant difference for FSTTS, TUGT, and HGS between the Baduanjin exercise and control groups in terms of baseline. The intervention group showed a marginally significant improvement in the FTSST (<italic>P</italic> = 0.008) and TUGT (<italic>P</italic> = 0.040), but no statistically significant difference in HGS (<italic>P</italic> = 0.484) over the 12 weeks compared to the control group (<xref ref-type="fig" rid="F3">Figure 3</xref>). From the rate of change, the exercise group only decreases the time to perform FTSST by 5.27 &#x000B1; 12.56% and perform TUGT by 6.78 &#x000B1; 13.10%, increasing HGS by 4.74 &#x000B1; 23.05%. At the same time, the percent change in the FTSST, TUGT, and HGS in the control group were 0.05 &#x000B1; 0.36%, 0.48 &#x000B1; 4.05%, and &#x02212;0.07 &#x000B1; 0.77%, respectively (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Comparison of baseline and follow-up physical function.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-08-789521-g0003.tif"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Percentage changes in physical function of the Baduanjin exercise and the control groups.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-08-789521-g0004.tif"/>
</fig>
</sec>
<sec>
<title>Health-Related Quality of Life</title>
<p>There was no significant difference for HRQOL between the Baduanjin exercise and control groups at baseline. Although there was the only effect of kidney disease significantly improved within the Baduanjin exercise group (<italic>P</italic> = 0.02; <xref ref-type="table" rid="T2">Table 2</xref>), it was observed that HRQOL significantly improved in the fields of the physical component score, mental component score, and effect of kidney disease in comparison to control group following Baduanjin exercise program (<italic>P</italic> &#x0003C; 0.01; <xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Comparison of HRQOL between two groups.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Exercise group (</bold><italic><bold>n</bold></italic> <bold>&#x0003D; 25)</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Control (</bold><italic><bold>n</bold></italic> <bold>&#x0003D; 32)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic><xref ref-type="table-fn" rid="TN2"><sup><bold>&#x00023;</bold></sup></xref></bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Baseline</bold></th>
<th valign="top" align="center"><bold>12 weeks</bold></th>
<th valign="top" align="center"><bold><italic>Z</italic></bold></th>
<th valign="top" align="center"><bold><italic>P<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></italic></bold></th>
<th valign="top" align="center"><bold>Baseline</bold></th>
<th valign="top" align="center"><bold>12 weeks</bold></th>
<th valign="top" align="center"><bold><italic>Z</italic></bold></th>
<th valign="top" align="center"><bold><italic>P<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></italic></bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">PCS</td>
<td valign="top" align="center">41.7 (35.4, 75.0)</td>
<td valign="top" align="center">58.3 (45.8, 70.8)</td>
<td valign="top" align="center">&#x02212;1.172</td>
<td valign="top" align="center">0.241</td>
<td valign="top" align="center">39.6 (17.7, 57.3)</td>
<td valign="top" align="center">40.0 (26.1, 46.5)</td>
<td valign="top" align="center">&#x02212;0.290</td>
<td valign="top" align="center">0.772</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">MCS</td>
<td valign="top" align="center">65.0 (42.9, 75.4)</td>
<td valign="top" align="center">69.2 (54.6, 74.6)</td>
<td valign="top" align="center">&#x02212;0.592</td>
<td valign="top" align="center">0.554</td>
<td valign="top" align="center">65.4 (39.8, 78.4)</td>
<td valign="top" align="center">54.2 (45.7, 60.0)</td>
<td valign="top" align="center">&#x02212;1.216</td>
<td valign="top" align="center">0.224</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">BKD</td>
<td valign="top" align="center">37.5 (18.8, 56.3)</td>
<td valign="top" align="center">37.5 (28.8, 46.9)</td>
<td valign="top" align="center">&#x02212;0.029</td>
<td valign="top" align="center">0.977</td>
<td valign="top" align="center">43.8 (18.8, 56.3)</td>
<td valign="top" align="center">37.5 (31.3, 43.8)</td>
<td valign="top" align="center">&#x02212;0.587</td>
<td valign="top" align="center">0.557</td>
<td valign="top" align="center">0.673</td>
</tr>
<tr>
<td valign="top" align="left">S/P</td>
<td valign="top" align="center">77.1 (65.7, 81.3)</td>
<td valign="top" align="center">77.1 (70.9, 81.3)</td>
<td valign="top" align="center">&#x02212;1.252</td>
<td valign="top" align="center">0.211</td>
<td valign="top" align="center">75.0 (62.5, 83.3)</td>
<td valign="top" align="center">75.0 (70.8, 79.2)</td>
<td valign="top" align="center">&#x02212;0.854</td>
<td valign="top" align="center">0.393</td>
<td valign="top" align="center">0.309</td>
</tr>
<tr>
<td valign="top" align="left">EKD</td>
<td valign="top" align="center">62.5 (51.6, 68.8)</td>
<td valign="top" align="center">68.8 (56.3, 71.9)</td>
<td valign="top" align="center">&#x02212;2.315</td>
<td valign="top" align="center">0.021</td>
<td valign="top" align="center">62.5 (47.7, 75.0)</td>
<td valign="top" align="center">56.3 (44.6, 62.5)</td>
<td valign="top" align="center">&#x02212;1.106</td>
<td valign="top" align="center">0.269</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>PCS, physical component score; MCS, mental component score; BKD, burden of kidney disease; S/P, symptom/problem; EKD, effect of kidney disease</italic>.</p>
<p><italic>Data are represented as median with the interquartile range</italic>.</p>
<fn id="TN1"><label>&#x0002A;</label><p><italic>Comparison of HRQOL at baseline and 12 weeks within groups</italic>.</p></fn>
<fn id="TN2"><label>&#x00023;</label><p><italic>Comparison of HRQOL at 12 weeks between the Baduanjin exercise and the control groups</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>To our knowledge, this is the first randomized trial of the Baduanjin exercise program in PD patients, so direct comparison with prior studies is limited. Our study suggests that a 12-week Baduanjin exercise program may improve physical function and HRQOL in PD patients. This finding is consistent with results published by Bennet et al. (<xref ref-type="bibr" rid="B20">20</xref>), who demonstrated a statistically significant improvement in physical mobility, measured by TUGT, in PD patients who followed a combined resistance and aerobic exercise program.</p>
<p>The poor physical function puts the patients at risk of impaired HRQOL and higher mortality among PD patients linked to a more sedentary lifestyle (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Regular exercise programs or encouraging increased physical activity may improve the prognosis of PD patients (<xref ref-type="bibr" rid="B22">22</xref>). Consistent evidence shows that the Baduanjin exercise program improved physical function (e.g., balance ability, cardiopulmonary fitness, and functional mobility) in Parkinson&#x00027;s disease patients (<xref ref-type="bibr" rid="B23">23</xref>). Our results complement prior researches on exercise programs on physical function in PD patients. This study showed an increase in FTSST by 5.27% and TUGT by 6.78% in the Baduanjin exercise group. The findings are somewhat similar to Uchiyama et al. (<xref ref-type="bibr" rid="B24">24</xref>) but are slightly lower than Lo&#x00027;s study (<xref ref-type="bibr" rid="B25">25</xref>). In previous reports, Uchiyama et al. (<xref ref-type="bibr" rid="B24">24</xref>) conducted a randomized controlled trial of 24 PD patients, and results showed that 12-week home-based aerobic exercise improved incremental shuttle walking test, an indicator that assesses mobility, compared to the control group (<xref ref-type="bibr" rid="B24">24</xref>). Similarly, another study of 13 PD patients demonstrated that aerobic capacity increased by 16.2% after a 12-week exercise program (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>In the present study, HRQOL was assessed using the KDQOL-SF. The scores that we recorded at baseline before the intervention are similar to those reported by Hiramatsu et al. (<xref ref-type="bibr" rid="B26">26</xref>) in a sample of PD patients. Of particular note is the observation that our 12-week intervention led to a mean increase of FTSST and TUGT in the Baduanjin exercise group and HRQOL with a corresponding change in both. Increased muscle strength and functional mobility may significantly impact HRQOL as daily activities require submaximal efforts. Meanwhile, we observed there was a trend of deterioration in HRQOL in the control group. As everyone knows, PD patients have a more severe disease burden and progressively worsen over time, making their HRQOL unpleasant. Maintenance even increases in physical function are considered as a key to improving HRQOL (<xref ref-type="bibr" rid="B27">27</xref>). Our results illustrate further this view.</p>
<p>Several limitations of the study should be noted. Firstly, the rate of lost participants in the current study was relatively high, which might impact the reliability of results to a certain extent. Secondly, among exercise programs, this study lacks precise tools (e.g., accelerometer) to monitor the exercise intensity of patients, although Baduanjin is low-to-moderate intensity. Thirdly, despite our results illustrating that Baduanjin shows at least short-term physical function benefits, studies of even longer duration are required to clarify the role of Baduanjin in the prognosis of PD patients.</p>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusion</title>
<p>In summary, a 12-week Baduanjin exercise program effectively improved physical function and improved some aspects of HRQOL among PD patients. Larger studies and longer follow-up are needed to determine if these findings will decrease the risk of disease progression.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Ethics Committee of Longhua Hospital Shanghai University Traditional Chinese Medicine. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>QYS, LYH, and JL: research idea and study design. JL, WHZ, and HW: patient supervision and data acquisition. FZ: data analysis. FZ and HCZ: writing a draft and revising. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This study was supported by Longhua Hospital Shanghai University Traditional Chinese Medicine (Y1829 and Y21026).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack><p>The authors thank the participants during the trial and the clinical teams at the department of nephrology.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>F</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Liu</surname> <given-names>B</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Prevalence of chronic kidney disease in China: a cross-sectional survey</article-title>. <source>Lancet.</source> (<year>2012</year>) <volume>379</volume>:<fpage>815</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60033-6</pub-id><pub-id pub-id-type="pmid">24559433</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname> <given-names>AC</given-names></name> <name><surname>Nagler</surname> <given-names>EV</given-names></name> <name><surname>Morton</surname> <given-names>RL</given-names></name> <name><surname>Masson</surname> <given-names>P</given-names></name></person-group>. <article-title>Chronic kidney disease</article-title>. <source>Lancet.</source> (<year>2017</year>) <volume>389</volume>:<fpage>1238</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)32064-5</pub-id><pub-id pub-id-type="pmid">27887750</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>F</given-names></name> <name><surname>Yang</surname> <given-names>C</given-names></name> <name><surname>Long</surname> <given-names>J</given-names></name> <name><surname>Zhao</surname> <given-names>X</given-names></name> <name><surname>Tang</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET)</article-title>. <source>Kidney Int.</source> (<year>2019</year>) <volume>95</volume>:<fpage>501</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2018.11.011</pub-id><pub-id pub-id-type="pmid">31331481</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname> <given-names>PL</given-names></name> <name><surname>Agarwal</surname> <given-names>A</given-names></name> <name><surname>Drummond</surname> <given-names>M</given-names></name></person-group>. <article-title>Physical function and physical activity in peritoneal dialysis patients</article-title>. <source>Perit Dial Int.</source> (<year>2017</year>) <volume>37</volume>:<fpage>598</fpage>&#x02013;<lpage>604</lpage>. <pub-id pub-id-type="doi">10.3747/pdi.2016.00256</pub-id><pub-id pub-id-type="pmid">32361700</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>SH</given-names></name> <name><surname>Do</surname> <given-names>JY</given-names></name> <name><surname>Jeong</surname> <given-names>HY</given-names></name> <name><surname>Lee</surname> <given-names>SY</given-names></name> <name><surname>Kim</surname> <given-names>JC</given-names></name></person-group>. <article-title>The clinical significance of physical activity in maintenance dialysis patients</article-title>. <source>Kidney Blood Press Res.</source> (<year>2017</year>) <volume>42</volume>:<fpage>575</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1159/000480674</pub-id><pub-id pub-id-type="pmid">29017151</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isnard-Rouchon</surname> <given-names>M</given-names></name> <name><surname>West</surname> <given-names>M</given-names></name> <name><surname>Bennett</surname> <given-names>PN</given-names></name></person-group>. <article-title>Exercise and physical activity for people receiving peritoneal dialysis: why not?</article-title> <source>Semin Dial.</source> (<year>2019</year>) <volume>32</volume>:<fpage>303</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/sdi.12784</pub-id><pub-id pub-id-type="pmid">30907025</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uchiyama</surname> <given-names>K</given-names></name> <name><surname>Washida</surname> <given-names>N</given-names></name> <name><surname>Morimoto</surname> <given-names>K</given-names></name> <name><surname>Muraoka</surname> <given-names>K</given-names></name> <name><surname>Nakayama</surname> <given-names>T</given-names></name> <name><surname>Adachi</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: a <italic>post-hoc</italic> analysis of a randomized controlled trial</article-title>. <source>Ther Apher Dial.</source> (<year>2020</year>) <volume>24</volume>:<fpage>668</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/1744-9987.13481</pub-id><pub-id pub-id-type="pmid">31997526</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellizzi</surname> <given-names>V</given-names></name> <name><surname>Regolisti</surname> <given-names>G</given-names></name></person-group>. <article-title>What is the role of exercise in chronic kidney disease?</article-title> [published online ahead of print, 2020 Aug 12]. <source>Nephrol Dial Transplant</source>. (<year>2020</year>) <fpage>gfaa161</fpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfaa161</pub-id><pub-id pub-id-type="pmid">32785698</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maia Neves Menezes</surname> <given-names>JI</given-names></name> <name><surname>Lopes Pereira</surname> <given-names>LA</given-names></name></person-group>. <article-title>Physical exercise and peritoneal dialysis: an area yet to be explored</article-title>. <source>Nefrologia.</source> (<year>2021</year>) <fpage>S0211</fpage>&#x02013;<lpage>6995</lpage>. <pub-id pub-id-type="doi">10.1016/j.nefro.2021.02.007</pub-id><pub-id pub-id-type="pmid">34419333</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>L</given-names></name> <name><surname>Pan</surname> <given-names>Z</given-names></name> <name><surname>Yeung</surname> <given-names>A</given-names></name> <name><surname>Talwar</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>A review study on the beneficial effects of baduanjin</article-title>. <source>J Altern Complement Med.</source> (<year>2018</year>) <volume>24</volume>:<fpage>324</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1089/acm.2017.0241</pub-id><pub-id pub-id-type="pmid">29227709</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>SJ</given-names></name> <name><surname>Ren</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Wei</surname> <given-names>GX</given-names></name> <name><surname>Zou</surname> <given-names>L</given-names></name></person-group>. <article-title>Mind<sup>&#x02212;</sup>Body (Baduanjin) exercise prescription for chronic obstructive pulmonary disease: a systematic review with meta-analysis</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2018</year>) <volume>15</volume>:<fpage>1830</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph15091830</pub-id><pub-id pub-id-type="pmid">30149535</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>J</given-names></name> <name><surname>Lin</surname> <given-names>T</given-names></name> <name><surname>Cai</surname> <given-names>Y</given-names></name> <name><surname>Chen</surname> <given-names>Q</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Ren</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Baduanjin exercise for type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Evid Based Complement Alternat Med.</source> (<year>2017</year>) <volume>2017</volume>:<fpage>8378219</fpage>. <pub-id pub-id-type="doi">10.1155/2017/8378219</pub-id><pub-id pub-id-type="pmid">29234435</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>DM</given-names></name> <name><surname>Yu</surname> <given-names>WC</given-names></name> <name><surname>Hung</surname> <given-names>HF</given-names></name> <name><surname>Tsai</surname> <given-names>JC</given-names></name> <name><surname>Wu</surname> <given-names>HY</given-names></name> <name><surname>Chiou</surname> <given-names>AF</given-names></name></person-group>. <article-title>The effects of Baduanjin exercise on fatigue and quality of life in patients with heart failure: a randomized controlled trial</article-title>. <source>Eur J Cardiovasc Nurs.</source> (<year>2018</year>) <volume>17</volume>:<fpage>456</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1177/1474515117744770</pub-id><pub-id pub-id-type="pmid">29189045</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>YH</given-names></name> <name><surname>Tan</surname> <given-names>C</given-names></name> <name><surname>Yuan</surname> <given-names>S</given-names></name></person-group>. <article-title>Baduanjin exercise for insomnia: a systematic review and meta-analysis</article-title>. <source>Behav Sleep Med.</source> (<year>2017</year>) <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/15402002.2017.1363042</pub-id><pub-id pub-id-type="pmid">28777659</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inker</surname> <given-names>LA</given-names></name> <name><surname>Astor</surname> <given-names>BC</given-names></name> <name><surname>Fox</surname> <given-names>CH</given-names></name> <name><surname>Isakova</surname> <given-names>T</given-names></name> <name><surname>Lash</surname> <given-names>JP</given-names></name> <name><surname>Peralta</surname> <given-names>CA</given-names></name> <etal/></person-group>. <article-title>KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD</article-title>. <source>Am J Kidney Dis.</source> (<year>2014</year>) <volume>63</volume>:<fpage>713</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2014.01.416</pub-id><pub-id pub-id-type="pmid">24647050</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname> <given-names>P</given-names></name> <name><surname>Marcus</surname> <given-names>RL</given-names></name></person-group>. <article-title>Assessing physical function and physical activity in patients with CKD</article-title>. <source>Clin J Am Soc Nephrol.</source> (<year>2013</year>) <volume>8</volume>:<fpage>861</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.2215/CJN.06590712</pub-id><pub-id pub-id-type="pmid">23220421</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hays</surname> <given-names>RD</given-names></name> <name><surname>Kallich</surname> <given-names>JD</given-names></name> <name><surname>Mapes</surname> <given-names>DL</given-names></name> <name><surname>Coons</surname> <given-names>SJ</given-names></name> <name><surname>Carter</surname> <given-names>WB</given-names></name></person-group>. <article-title>Development of the kidney disease quality of life (KDQOL) instrument</article-title>. <source>Qual Life Res.</source> (<year>1994</year>) <volume>3</volume>:<fpage>329</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/BF00451725</pub-id><pub-id pub-id-type="pmid">7841967</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname> <given-names>KL</given-names></name> <name><surname>Bryant</surname> <given-names>FB</given-names></name> <name><surname>Reda</surname> <given-names>DJ</given-names></name> <name><surname>Stroupe</surname> <given-names>KT</given-names></name> <name><surname>Hynes</surname> <given-names>DM</given-names></name></person-group>. <article-title>Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across veterans and non-veterans</article-title>. <source>Health Qual Life Outcomes.</source> (<year>2010</year>) <volume>8</volume>:<fpage>120</fpage>. <pub-id pub-id-type="doi">10.1186/1477-7525-8-120</pub-id><pub-id pub-id-type="pmid">20973987</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname> <given-names>X</given-names></name> <name><surname>Chow</surname> <given-names>SK</given-names></name> <name><surname>Wong</surname> <given-names>FK</given-names></name></person-group>. <article-title>Determining the validity and reliability of the Chinese version of the Kidney Disease Quality of Life Questionnaire (KDQOL-36&#x02122;)</article-title>. <source>BMC Nephrol.</source> (<year>2014</year>) <volume>15</volume>:<fpage>115</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2369-15-115</pub-id><pub-id pub-id-type="pmid">25015224</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennet</surname> <given-names>PN</given-names></name> <name><surname>Hussein</surname> <given-names>WF</given-names></name> <name><surname>Matthews</surname> <given-names>K</given-names></name> <name><surname>West</surname> <given-names>M</given-names></name> <name><surname>Smith</surname> <given-names>E</given-names></name> <name><surname>Reiterman</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>An exercise program for peritoneal dialysis patients in the United States: a feasibility study</article-title>. <source>Kidney Med.</source> (<year>2020</year>) <volume>2</volume>:<fpage>267</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.xkme.2020.01.005</pub-id><pub-id pub-id-type="pmid">32734246</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>KL</given-names></name> <name><surname>Chertow</surname> <given-names>GM</given-names></name> <name><surname>Kutner</surname> <given-names>NG</given-names></name> <name><surname>Dalrymple</surname> <given-names>LS</given-names></name> <name><surname>Grimes</surname> <given-names>BA</given-names></name> <name><surname>Kaysen</surname> <given-names>GA</given-names></name></person-group>. <article-title>Low level of self-reported physical activity in ambulatory patients new to dialysis</article-title>. <source>Kidney Int.</source> (<year>2010</year>) <volume>78</volume>:<fpage>1164</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2010.312</pub-id><pub-id pub-id-type="pmid">20811334</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname> <given-names>S</given-names></name></person-group>. <article-title>Do we need tailored physical interventions to improve physical function and physical activity levels in patients with chronic kidney disease treated with peritoneal dialysis?</article-title> <source>Perit Dial Int.</source> (<year>2017</year>) <volume>37</volume>:<fpage>595</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3747/pdi.2017.00138</pub-id><pub-id pub-id-type="pmid">29123000</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>CM</given-names></name> <name><surname>Zhuang</surname> <given-names>YC</given-names></name></person-group>. <article-title>Effect of health Baduanjin Qigong for mild to moderate Parkinson&#x00027;s disease</article-title>. <source>Geriatr Gerontol Int.</source> (<year>2016</year>) <volume>16</volume>:<fpage>911</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/ggi.12571</pub-id><pub-id pub-id-type="pmid">26310941</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uchiyama</surname> <given-names>K</given-names></name> <name><surname>Washida</surname> <given-names>N</given-names></name> <name><surname>Morimoto</surname> <given-names>K</given-names></name> <name><surname>Muraoka</surname> <given-names>K</given-names></name> <name><surname>Kasai</surname> <given-names>T</given-names></name> <name><surname>Yamaki</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Home-based aerobic exercise and resistance training in peritoneal dialysis patients: a randomized controlled trial</article-title>. <source>Sci Rep.</source> (<year>2019</year>) <volume>9</volume>:<fpage>2632</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-39074-9</pub-id><pub-id pub-id-type="pmid">30796338</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>CY</given-names></name> <name><surname>Li</surname> <given-names>L</given-names></name> <name><surname>Lo</surname> <given-names>WK</given-names></name> <name><surname>Chan</surname> <given-names>ML</given-names></name> <name><surname>So</surname> <given-names>E</given-names></name> <name><surname>Tang</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Benefits of exercise training in patients on continuous ambulatory peritoneal dialysis</article-title>. <source>Am J Kidney Dis.</source> (<year>1998</year>) <volume>32</volume>:<fpage>1011</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0272-6386(98)70076-9</pub-id><pub-id pub-id-type="pmid">9856517</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiramatsu</surname> <given-names>T</given-names></name> <name><surname>Okumura</surname> <given-names>S</given-names></name> <name><surname>Asano</surname> <given-names>Y</given-names></name> <name><surname>Mabuchi</surname> <given-names>M</given-names></name> <name><surname>Iguchi</surname> <given-names>D</given-names></name> <name><surname>Furuta</surname> <given-names>S</given-names></name></person-group>. <article-title>Quality of life and emotional distress in peritoneal dialysis and hemodialysis patients</article-title>. <source>Ther Apher Dial.</source> (<year>2019</year>) <volume>24</volume>:<fpage>366</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/1744-9987.13450</pub-id><pub-id pub-id-type="pmid">31671240</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyasere</surname> <given-names>O</given-names></name> <name><surname>Brown</surname> <given-names>E</given-names></name> <name><surname>Gordon</surname> <given-names>F</given-names></name> <name><surname>Collinson</surname> <given-names>H</given-names></name> <name><surname>Fielding</surname> <given-names>R</given-names></name> <name><surname>Fluck</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Longitudinal trends in quality of life and physical function in frail older dialysis patients: a comparison of assisted peritoneal dialysis and in-center hemodialysis</article-title>. <source>Perit Dial Int.</source> (<year>2019</year>) <volume>39</volume>:<fpage>112</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3747/pdi.2018.00086</pub-id><pub-id pub-id-type="pmid">30661007</pub-id></citation></ref>
</ref-list>
</back>
</article>